Virological monitoring of hepatitis C treatment in 2009

被引:0
|
作者
Cacoub, P. [1 ,2 ]
Halfon, P. [3 ]
机构
[1] Univ Paris 06, CNRS, UMR 7087, F-75013 Paris 13, France
[2] Hop La Pitie Salpetriere, AP HP, Serv Med Interne, F-75013 Paris, France
[3] Hop Ambroise Pare, Lab Virol Alphabio, Serv Malad Infect, F-13006 Marseille, France
来源
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 10期
关键词
HCV infection; Hepatitis C; Treatment; ALPHA-2B PLUS RIBAVIRIN; TREATMENT DURATION; PEGINTERFERON ALPHA-2A; VIRUS; GENOTYPE-1; INFECTION; TYPE-1; TRIAL;
D O I
10.1016/j.revmed.2009.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:838 / 840
页数:3
相关论文
共 50 条
  • [41] Does interferon treatment improve hepatic fibrosis in non virological responders with hepatitis C?
    Kikuchi, K
    Miyagi, M
    Hayashi, S
    Keida, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S93 - S93
  • [42] Predictive value and predictive factors of the rapid virological response in chronic hepatitis C treatment
    Galeras, J. A.
    Gimenez, M. D.
    Marquez, C.
    Cirera, I.
    Coll, S.
    Sola, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S212 - S213
  • [43] Could faluvastatin affect the sustained virological response in chronic hepatitis C virus treatment?
    El-Hamamsy, M.
    Azmy, M.
    Badr, G.
    Houssein, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S14 - S15
  • [44] New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings
    Chevaliez, Stephane
    Pawlotsky, Jean-Michel
    JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 916 - 926
  • [45] Relative impact of ribavirin monitoring and HIV coinfection on sustained virological response in patients with chronic hepatitis C
    Piedoux, Sarah
    Monnet, Elisabeth
    Piroth, Lionel
    Montange, Damien
    Royer, Bernard
    Thevenot, Thierry
    Kantelip, Jean Pierre
    Di Martino, Vincent
    Muret, Patrice
    ANTIVIRAL THERAPY, 2011, 16 (08) : 1317 - 1326
  • [46] Hepatitis C virus core antigen test in virological monitoring of patients on long-term dialysis
    Li Cavoli, Gioacchino
    Zagarrigo, Carmela
    Schillaci, Onofrio
    Tralongo, Angelo
    Rotolo, Ugo
    CLINICAL KIDNEY JOURNAL, 2010, 3 (03): : 334 - 334
  • [47] Optimal virologic monitoring of hepatitis C in 2009: Treatment duration depends on the speed of virologic response and the duration of the negative reaction
    Halfon, Philippe
    Ouzan, Denis
    PRESSE MEDICALE, 2009, 38 (7-8): : 1037 - 1040
  • [48] Hepatitis C reinfection after sustained virological response
    Midgard, Havard
    Bjoro, Benedikte
    Maeland, Arild
    Konopski, Zbigniew
    Kileng, Hege
    Damas, Jan K.
    Paulsen, Jorn
    Heggelund, Lars
    Sandvei, Per K.
    Ringstad, Jetmund O.
    Karlsen, Lars N.
    Stene-Johansen, Kathrine
    Pettersson, John H. -O.
    Dorenberg, Dagny H.
    Dalgard, Olav
    JOURNAL OF HEPATOLOGY, 2016, 64 (05) : 1020 - 1026
  • [49] Postsustained Virological Response Management in Hepatitis C Patients
    Masetti, Chiara
    Lleo, Ana
    Colombo, Matteo
    Colombo, Massimo
    Aghemo, Alessio
    SEMINARS IN LIVER DISEASE, 2020, 40 (03) : 233 - 239
  • [50] Virological characterization of hepatitis C virus healthy carriers
    Debette, M
    Coste, J
    Hyrailles, V
    Blanc, P
    Dubois, A
    Michel, H
    Larrey, D
    HEPATOLOGY, 1996, 23 (01) : P112 - P112